April 2025 - April 2026: first assessment of the QFarma merger (CEF + UNICO), €2.5 billion revenue, 12,000 pharmacies. What changed in the Italian intermediate distribution market, and which paths remain for regional independent wholesalers.
Read articleItalian decree 219/2006 mandates 12 working hours from pharmacy request. ADF declares 3-hour average. Controlled substances with no partial deliveries. Why morning perfect planning is no longer enough, and how dynamic intraday replanning works.
Read articleItalian intermediate pharmaceutical distribution (DIF) has average EBITDA of 1.5% (Polimi 2025), the lowest in the country's contract logistics. Structural causes, working capital role, concrete recovery levers.
Read articleWhat the AIFA inspector checks in a GDP audit at an Italian pharmaceutical wholesaler: quality documentation, vehicle thermal mapping, transporter qualification, lot traceability. Operational checklist and most frequent errors.
Read articleHippocrates, Dr.Max, LloydsFarmacia: how Italian pharmacy chains are building proprietary distribution centres and disintermediating DIF. The map, numbers, DD/DPC effect and what remains for regional independent distributors.
Read articlePolimi 2025: +19% kg transported but parcels per shipment declining for Italian pharmaceutical intermediate distribution. What it means for route planning, where hidden costs grow, how to respond with dynamic load balancing and cluster recomposition.
Read articleThe Italian TAR Lazio ruling of 9 February 2026 excludes generic drugs from the 0.65% additional margin introduced by the 2025 Budget Law. What changes for pharmaceutical wholesalers, estimated economic impact and possible moves.
Read articleHow much does it cost to serve a pharmacy for an Italian intermediate pharmaceutical wholesaler (DIF)? Cost components, step-by-step model, break-even basket and the three typical scenarios (urban, suburban, rural).
Read articleBook a free 30-minute demo. We'll show you Optivo with your data.
Find out how much you can save